These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30296919)

  • 1. Medication-related osteonecrosis of the jaw: An institution's experience.
    Altay MA; Radu A; Pack SE; Yıldırımyan N; Flores-Hidalgo A; Baur DA; Quereshy FA
    Cranio; 2020 Sep; 38(5):333-341. PubMed ID: 30296919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
    Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
    Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
    Zhou Y; Zhao N; Huang H; Li Q; Guo C; Guo Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):51-56. PubMed ID: 38318896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related osteonecrosis (MRONJ) of the mandible and maxilla.
    Dunphy L; Salzano G; Gerber B; Graystone J
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31907213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of severe medication-related osteonecrosis of the jaw.
    Feng Z; An J; Zhang Y; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):43-51. PubMed ID: 38596940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
    Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
    Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
    Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
    Cavalcante RC; Tomasetti G
    J Craniomaxillofac Surg; 2020 Nov; 48(11):1080-1086. PubMed ID: 32998853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.
    Palla B; Burian E; Deek A; Scott C; Anderson J; Callahan N; Carlson ER
    J Oral Maxillofac Surg; 2021 May; 79(5):1045-1052. PubMed ID: 33358707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib.
    Mauceri R; Panzarella V; Morreale I; Campisi G
    Int J Oral Maxillofac Surg; 2019 Dec; 48(12):1530-1532. PubMed ID: 31378564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?
    Fleisher KE; Pham S; Raad RA; Friedman KP; Ghesani M; Chan KC; Amintavakoli N; Janal M; Levine JP; Glickman RS
    J Oral Maxillofac Surg; 2016 May; 74(5):945-58. PubMed ID: 26657395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary study on the etiological characteristics and clinical treatment of medication-related osteonecrosis of the jaws].
    Hou W; Dong XT; Wu TT; Ma XF; Zhang XH; Hou CL; Liu XH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Jul; 56(7):659-664. PubMed ID: 34275221
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous bilateral osteonecrosis of the mandible in a bisphosphonate-naive patient.
    Sklavos AW; Delpachitra SN; Thomas AM; Nastri A
    Br J Oral Maxillofac Surg; 2019 Apr; 57(3):271-274. PubMed ID: 30773304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.